DIH Holding US sold an aggregate of $2,222,222 in principal of 8% Original Issue Discount senior secured convertible debentures, issued with a $222,222 original issue discount, resulting in approximately $2.0 million of gross proceeds and roughly $1.9 million net after offering expenses. The Debentures are initially convertible at $0.25 per share, subject to adjustment, and conversion is limited so a holder cannot exceed 9.99% beneficial ownership.
The Debentures mature in September 2026, carry an 8% annual rate with no interest payable during the first year and monthly redemptions beginning October 1, 2025 of $170,940.17 (payable in cash or, subject to formula limits, shares). Purchasers also received warrants for an aggregate of 8,888,888 shares at a $0.25 exercise price (five‑year term, exercisable February 1, 2026). The transaction includes registration rights covering the registrable securities and a voting agreement from Jason Chen in favor of required shareholder approvals.
DIH Holding US, Inc. (Nasdaq: DHAI) filed a Form 8-K reporting the 4 Aug 2025 appointment of Scott R. Burell to its Board of Directors. Burell, an experienced healthcare CFO now serving at AIVITA Biomedical and formerly at CombiMatrix during its sale to Invitae, joins as a Class III director with a term expiring at the 2026 annual meeting. He will also sit on the Audit, Compensation, and Nominating & Corporate Governance Committees, adding finance and transaction expertise to these key oversight bodies. The company noted no related-party transactions under Item 404 and did not disclose new compensatory arrangements. An accompanying press release (Ex. 99.1) dated 7 Aug 2025 announces the move. No other operational or financial updates were included.